Patent Ownership and the Impact of Interactions with Others
Risks to Ownership, Managing Agreements With Other Parties, Patent Prosecution Strategies
Recording of a 90-minute premium CLE webinar with Q&A
This CLE course will guide patent counsel on the impact interactions with others can have on patent ownership. The panel will discuss the interplay between conception and joint inventorship that can become critical to patent ownership in departing-employee and customer-interaction scenarios. The panel will also examine the implications of interactions with others and will provide best practices for protecting a company's interests.
Outline
- Risks to patent ownership from interactions with others
- Implications of interactions with other parties
- Guidance for protecting the company's patents
- Managing agreements with other parties
- Patent prosecution strategies in light of inventorship/ownership challenges
- Identifying and evaluating inventorship/ownership issues
- Risks to patent ownership from interactions with others
Benefits
The panel will review these and other key issues:
- How can interactions with others jeopardize patent ownership at risk?
- How should patent counsel manage agreements to minimize the risk to patent ownership?
- What steps should counsel take to identify potential patent ownership issues?
Faculty
Adam M. Breier, Ph.D.
Partner
McNeill Baur
Dr. Breier’s practice focuses on patent prosecution, client counseling, and PTAB proceedings in the biotechnology... | Read More
Dr. Breier’s practice focuses on patent prosecution, client counseling, and PTAB proceedings in the biotechnology and pharmaceutical areas. He coordinates global prosecution strategies, prepares domestic and foreign patent applications, performs freedom-to-operate, patentability, invalidity, and noninfringement analyses, and participates in post-grant administrative trials such as inter partes reviews. Dr. Breir has a special interest in subject matter including biochemical and biophysical analytical compositions, methods, and apparatuses; polymer chemistry; engineered or recombinant DNA, RNA, and proteins; and genetically modified cells. He also has prosecution experience with new chemical entities and with compositions and formulations in which hydrophobic or amphipathic materials such as lipids, polymers, or surfactants provide new and useful features. Dr. Breir has worked with domestic and foreign clients, including research institutions, startups, and established biotechnology, pharmaceutical, and chemical companies.
Close
Rebecca M. McNeill
Partner
McNeill
Ms. McNeill offers intellectual property strategy and advises on new application preparation, patent prosecution (U.S.... | Read More
Ms. McNeill offers intellectual property strategy and advises on new application preparation, patent prosecution (U.S. and foreign), and preparation and negotiation of IP transactions, and provides the full scope of counseling services. She has a special interest in counseling clients on patent application filing and developing worldwide prosecution strategies in concert with clients’ business goals. She has managed and directed the U.S. and international patent portfolios for U.S. clients and has overseen the U.S. patent portfolio for international clients in Europe and Asia.
Close